- Home
- CATX vs LEGT Comparison
CATX vs LEGT Comparison
Compare CATX & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- LEGT
- Stock Information
- Founded
- CATX 1983
- LEGT 2023
- Country
- CATX United States
- LEGT United States
- Employees
- CATX N/A
- LEGT N/A
- Industry
- CATX Medical/Dental Instruments
- LEGT
- Sector
- CATX Health Care
- LEGT
- Exchange
- CATX Nasdaq
- LEGT Nasdaq
- Market Cap
- CATX 239.0M
- LEGT 276.8M
- IPO Year
- CATX N/A
- LEGT 2024
- Fundamental
- Price
- CATX $3.27
- LEGT $10.74
- Analyst Decision
- CATX Strong Buy
- LEGT
- Analyst Count
- CATX 11
- LEGT 0
- Target Price
- CATX $12.90
- LEGT N/A
- AVG Volume (30 Days)
- CATX 696.8K
- LEGT 21.8K
- Earning Date
- CATX 11-11-2025
- LEGT 01-01-0001
- Dividend Yield
- CATX N/A
- LEGT N/A
- EPS Growth
- CATX N/A
- LEGT N/A
- EPS
- CATX N/A
- LEGT 0.35
- Revenue
- CATX $1,235,000.00
- LEGT N/A
- Revenue This Year
- CATX N/A
- LEGT N/A
- Revenue Next Year
- CATX N/A
- LEGT N/A
- P/E Ratio
- CATX N/A
- LEGT $30.68
- Revenue Growth
- CATX N/A
- LEGT N/A
- 52 Week Low
- CATX $1.60
- LEGT $10.18
- 52 Week High
- CATX $14.19
- LEGT $10.86
- Technical
- Relative Strength Index (RSI)
- CATX 44.58
- LEGT 50.08
- Support Level
- CATX $3.02
- LEGT $10.75
- Resistance Level
- CATX $3.74
- LEGT $10.74
- Average True Range (ATR)
- CATX 0.25
- LEGT 0.01
- MACD
- CATX -0.01
- LEGT 0.00
- Stochastic Oscillator
- CATX 29.52
- LEGT 33.33
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.